Articles related to LIPID HEALTH

A meta-analysis published in JAMA Internal Medicine has concluded that the link between statin-induced LDL lowering and reduction of CV outcomes may not be as robust as previously assumed. According to the researchers, the absolute risk reduction associated with statin use for all-cause mortality was 0.8% (95% CI, 0.4-1.2), whereas for MI it was 1.3% (95% CI, 0.9-1.7) and for stroke it was 0.4% (95% CI, 0.2-0.6). Absolute risk reduction figures were slightly higher for secondary prevention than for primary prevention.

Provide your patients with this checklist of more than a dozen foods to help them lower their cholesterol. From almonds to orange juice, avocadoes to soy, the nutritional weapons against heart disease, stroke, and other ailments is vast.

Our understanding of lipid pathology is shifting from what might be called the “LDL hypothesis” to the “atherogenic lipoprotein hypothesis.” LDL is just a surrogate of the actual process of lipoprotein interaction with the arterial wall. This shift in understanding is driving a host of budding therapies with novel approaches to targeting key atherogenesis players like lipoprotein(a) and triglycerides.

A population-based longitudinal study in Korea showed relationships between high-density lipoprotein cholesterol (HDL-C) levels and variability with incident Parkinson’s disease (PD). People with a baseline HDL-C under 40 mg/dL were more likely to develop PD than those with HDL-C of 60 mg/dL or more, confirming previous findings but still questioning how variability in HDL-C may be linked to PD.